2023-01-24 19:10:00

Bioxytran Interview at the Emerging Growth Conference

Logo Benzinga
By Globe Newswire

- Wednesday, January 25, 2023 10:50 am 11:20am EST

- Discussion of the Biotech Showcase Conference

BOSTON, MASSACHUSETTS, Jan. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. BIXT (the "Company"), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19 and other viral causing diseases announced that Bioxtran CMO Michael Sheikh will be discussing his attendance at the Biotech Showcase on the Emerging Growth Conference on January 25, 2023 at 10:50am EST. Investors are encouraged to preregister to ensure you are able to attend the conference and receive any updates that are released.

Event: Emerging Growth Conference

Date: January 25, 2023

Registration: https://goto.webcasts.com/starthere.jsp?ei=1575092&tp_key=9111d280ed&sti=bixt

Continue read on benzinga.com

Logo PR Newswire
HealthPress Release2023-01-24 12:00:00
REHOVOT, Israel, Jan. 24, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics,...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
CARMEL, Ind., Jan. 24, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo GlobeNewswire
SciencePress Release2023-01-24 12:00:00
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (First Wave BioPharma or the Company), a clinical-stage...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 14:21:00
Company cofounder to discuss use of artificial intelligence and machine learning applications for precision medicine in neurology BOSTON, Jan. 24, 2023...

Logo GlobeNewswire
SciencePress Release2023-01-24 09:00:00
AVT02 as Simlandi is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure REYKJAVIK, Iceland and DUBAI, United Arab...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:36:00
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix, Inc., a privately...

Logo PR Newswire
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at...

Logo GlobeNewswire
SciencePress Release2023-01-24 06:30:00
Press Release Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023 January 24, 2023 release at 7:30 am CET Sophia...

Logo PR Newswire
HealthPress Release2023-01-24 12:36:00
Treatment IDE Will Provide Opportunity to Treat Additional Patients in the US SAN RAMON, Calif., Jan. 24, 2023 /PRNewswire/ -- BioVentrix ®, Inc., a...

Logo GlobeNewswire
SciencePress Release2023-01-23 21:05:00
SEATTLE, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology...

Logo GlobeNewswire
SciencePress Release2023-01-24 13:00:00
BOSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system (CNS)...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 12:45:00
Phase 1/2 clinical trial expected to launch in early 2023 and will evaluate safety and preliminary impact on disease activity of IMPT-314 WEST HILLS, Calif.,...

Logo PR Newswire
SAN JOSE, Calif., Jan. 24, 2023 /PRNewswire/ -- Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. ("MGI"),...

Logo EIN Presswire
HealthPress Release2023-01-24 14:43:13
Emergen Research Logo Increase in the number of biopharmaceutical companies across the nations driving the growth of next-generation biomanufacturing in...

Logo The Business Journals
Technology2023-01-23 19:47:07
Genetesis has added three new executives to its team as it nears a key FDA approval.

Logo GlobeNewswire
HealthPress Release2023-01-24 13:30:00
HOUSTON, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the Company or Nexalin) (Nasdaq: NXL; NXLIW), today announced the appointment of Michael...

Logo GlobeNewswire
EconomyPress Release2023-01-24 15:00:00
Biohacking Market Trends and Insights Type (Inside, Outside), Product (Smart Drugs, Sensors, Strains), Application (Synthetic, Genetic Engineering), End-user...

Logo GlobeNewswire
SciencePress Release2023-01-24 11:00:00
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hemostemix Inc. (TSXV:HEM) (OTCQB:HMTXF) (FSE:2VF0), an autologous stem cell therapy company,...

Logo Nasdaq
Business / FinanceBy Rtt News2023-01-24 10:06:59
(RTTNews) - Alvotech (ALVO) and Bioventure Tuesday announced manufacturing and distribution approval of AVT02, a biosimilar of Humira, by the Saudi Food and...